Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

Oliver-Caldes, Aina; Gonzalez-Calle, Veronica; Cabanas, Valentin; et al; (31/31) de Larrea, Carlos Fernandez (AC). 2023. Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CART-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA- HCB-01): a single-arm, multicentre, academic pilot study. Lancet Oncology. ELSEVIER SCIENCE INC. 24-8, pp.913-924. ISSN 1470-2045. WOS (1)
The Lancet Oncology